Latest News & Features
Americas
The US Court of Appeals for the Federal Circuit affirmed a lower court’s claim construction of a patent which covers Sunovion’s schizophrenia and bipolar depression drug Latuda on Monday, April 16. 19 April 2018
Europe
France-based Sanofi has confirmed it is in negotiations to sell its European generics business Zentiva for €1.9 billion ($2.4 billion) to private equity firm Advent International. 19 April 2018
Asia-Pacific
China’s government has announced a series of measures to increase the country’s importation of drugs, including enhanced IP protection in the pharmaceutical industry. 18 April 2018
Biotechnology
Biotech company Shire has revealed plans to sell its oncology business for $2.4 billion to France-based Servier. 17 April 2018
Americas
Courts have not always been able to appreciate the complexities around antibody patents, causing problems for innovation and investment, says Eli Lilly patent counsel Duane Marks in an interview with LSIPR. 17 April 2018
Americas
The founder of a Canadian online pharmacy has been sentenced to house arrest and his company fined $34 million for importing counterfeit drugs into the US. 16 April 2018
Americas
Vanda Pharmaceuticals, a biopharmaceutical company based in Washington, DC, secured a win late last week when the US Court of Appeals for the Federal Circuit found a patent covering its schizophrenia drug to be patentable. 16 April 2018
Big Pharma
Ireland-based Cosmo Pharmaceuticals has lost a legal battle against Valeant Pharmaceuticals, costing it $3 million. 16 April 2018
Americas
Orchard Therapeutics has acquired GSK’s gene therapy portfolio, in an agreement intended to advance Orchard’s work in the field of rare diseases and allow GSK to focus on oncology. 13 April 2018
article
Variable sequence IP is fertile ground for potential validity challenges based on prior art or lack of enablement, as Ellen Sherin of GQ Life Sciences reports. 12 April 2018